Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 15,000 shares at $50.97 ($756K) on 2015-01-05, disclosed to the SEC on 2015-01-06.
Scheduled sale ($756k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.23 | 11,000 | $553K | 73.0% |
| 2 | $50.97 | 4,000 | $204K | 27.0% |
| Total | $50.43 avg | 15,000 | $756K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |